CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma
Clinical trial NCT06641453 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06641453
- Sponsor
- Chinese PLA General Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-15
- Primary completion
- 2027-11-15
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.